These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 14984373)

  • 1. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.
    Madisch A; Holtmann G; Plein K; Hotz J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):271-9. PubMed ID: 14984373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines for treatment of irritable bowel syndrome.
    Liu JP; Yang M; Liu YX; Wei M; Grimsgaard S
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004116. PubMed ID: 16437473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.
    Brinkhaus B; Hentschel C; Von Keudell C; Schindler G; Lindner M; Stützer H; Kohnen R; Willich SN; Lehmacher W; Hahn EG
    Scand J Gastroenterol; 2005 Aug; 40(8):936-43. PubMed ID: 16173134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
    Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
    Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.
    Mitchell SA; Mee AS; Smith GD; Palmer KR; Chapman RW
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1187-95. PubMed ID: 12030962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of an herbal medicine, Carmint, on the relief of abdominal pain and bloating in patients with irritable bowel syndrome: a pilot study.
    Vejdani R; Shalmani HR; Mir-Fattahi M; Sajed-Nia F; Abdollahi M; Zali MR; Mohammad Alizadeh AH; Bahari A; Amin G
    Dig Dis Sci; 2006 Aug; 51(8):1501-7. PubMed ID: 16868824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.
    Ottillinger B; Storr M; Malfertheiner P; Allescher HD
    Wien Med Wochenschr; 2013 Feb; 163(3-4):65-72. PubMed ID: 23263639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial.
    Lauche R; Kumar S; Hallmann J; Lüdtke R; Rampp T; Dobos G; Langhorst J
    Complement Ther Med; 2016 Jun; 26():171-7. PubMed ID: 27261998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review.
    Rahimi R; Abdollahi M
    World J Gastroenterol; 2012 Feb; 18(7):589-600. PubMed ID: 22363129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine.
    Allam S; Krueger D; Demir IE; Ceyhan G; Zeller F; Schemann M
    Phytomedicine; 2015 Nov; 22(12):1063-70. PubMed ID: 26547528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone treatment for irritable bowel syndrome--a randomized controlled trial with an oral formulation.
    Hawkes ND; Rhodes J; Evans BK; Rhodes P; Hawthorne AB; Thomas GA
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1649-54. PubMed ID: 12197844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
    Kim HJ; Camilleri M; McKinzie S; Lempke MB; Burton DD; Thomforde GM; Zinsmeister AR
    Aliment Pharmacol Ther; 2003 Apr; 17(7):895-904. PubMed ID: 12656692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Hawrelak JA; Wohlmuth H; Pattinson M; Myers SP; Goldenberg JZ; Harnett J; Cooley K; Van De Venter C; Reid R; Whitten DL
    Complement Ther Med; 2020 Jan; 48():102233. PubMed ID: 31987249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
    Glende M; Morselli-Labate AM; Battaglia G; Evangelista S
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
    Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.